| Dr Michael C Lipke, MD | |
|
9427 Sw Barnes Rd, Portland, OR 97225-6652 | |
| (503) 203-2120 | |
| Not Available |
| Full Name | Dr Michael C Lipke |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 25 Years |
| Location | 9427 Sw Barnes Rd, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104811801 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD00046383 (Washington) | Secondary |
| 208800000X | Urology | MD26747 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Sunnyside Medical Center | Clackamas, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.
Boston Scientific Corporation today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT II and MADIT-CRT, each exclusively sponsored by Boston Scientific and conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester.
The editors of Tissue Engineering asked 24 leaders in the field what critical steps are needed for tissue engineering to achieve broad critical success by the year 2021 and published their findings in the December 2007 issue (Volume 13, Number 12).
Radient Pharmaceuticals Corporation today announced it has received notice from the NYSE Amex that the Company is not in compliance with the continued listing standard in Section 1003(a)(iv) of the Exchange's Company Guide. The Company has until January 22, 2010 to submit a plan to regain compliance by June 23, 2010.
The State University of New York has received two grants totaling more than $4.3 million from the National Institutes of Health (NIH) to support neuroscience and pediatric pharmacology and vision research as part of SUNY REACH, a collaborative research network of SUNY's four academic health centers and the College of Optometry.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.
Boston Scientific Corporation today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT II and MADIT-CRT, each exclusively sponsored by Boston Scientific and conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester.
The editors of Tissue Engineering asked 24 leaders in the field what critical steps are needed for tissue engineering to achieve broad critical success by the year 2021 and published their findings in the December 2007 issue (Volume 13, Number 12).
Radient Pharmaceuticals Corporation today announced it has received notice from the NYSE Amex that the Company is not in compliance with the continued listing standard in Section 1003(a)(iv) of the Exchange's Company Guide. The Company has until January 22, 2010 to submit a plan to regain compliance by June 23, 2010.
The State University of New York has received two grants totaling more than $4.3 million from the National Institutes of Health (NIH) to support neuroscience and pediatric pharmacology and vision research as part of SUNY REACH, a collaborative research network of SUNY's four academic health centers and the College of Optometry.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael C Lipke, MD 9427 Sw Barnes Rd, Portland, OR 97225-6652 Ph: (503) 203-2120 | Dr Michael C Lipke, MD 9427 Sw Barnes Rd, Portland, OR 97225-6652 Ph: (503) 203-2120 |
News Archive
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.
Boston Scientific Corporation today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT II and MADIT-CRT, each exclusively sponsored by Boston Scientific and conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester.
The editors of Tissue Engineering asked 24 leaders in the field what critical steps are needed for tissue engineering to achieve broad critical success by the year 2021 and published their findings in the December 2007 issue (Volume 13, Number 12).
Radient Pharmaceuticals Corporation today announced it has received notice from the NYSE Amex that the Company is not in compliance with the continued listing standard in Section 1003(a)(iv) of the Exchange's Company Guide. The Company has until January 22, 2010 to submit a plan to regain compliance by June 23, 2010.
The State University of New York has received two grants totaling more than $4.3 million from the National Institutes of Health (NIH) to support neuroscience and pediatric pharmacology and vision research as part of SUNY REACH, a collaborative research network of SUNY's four academic health centers and the College of Optometry.
› Verified 9 days ago
Donald Andrew Young Iii, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 5050 Ne Hoyt St, Suite 514, Portland, OR 97213 Phone: 503-488-2323 Fax: 503-488-2340 | |
Dr. James Christopher Austin, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Pediatric Urology Cdw-6, Portland, OR 97239 Phone: 503-494-4808 Fax: 503-494-4743 | |
Lauren Lamina, Urology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-8311 | |
Dr. Jin-hee Kim, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 10000 Se Main St, Ste 342, Portland, OR 97216 Phone: 503-255-5244 Fax: 503-255-5120 | |
Michael Joseph Conlin, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3303 Sw Bond Ave, Ch10u, Portland, OR 97239 Phone: 503-494-4779 Fax: 503-494-8671 | |
Dr. James M Keane, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 9155 Sw Barnes Rd, Ste 422, Portland, OR 97225 Phone: 503-297-1078 Fax: 503-292-2176 | |
Marshall Strother, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3303 S Bond Ave, Portland, OR 97239 Phone: 503-346-1500 Fax: 503-494-8671 |